精品无吗Av一区二区_日韩亚洲中文无码_国产免费久久精品44_看全色黄大色黄大片不卡

<menu id="f7g4m"><button id="f7g4m"></button></menu>

<address id="f7g4m"><var id="f7g4m"><ruby id="f7g4m"></ruby></var></address>

<object id="f7g4m"><ol id="f7g4m"><th id="f7g4m"></th></ol></object>

<center id="f7g4m"><style id="f7g4m"><b id="f7g4m"></b></style></center>

Innovation Recognized Again: Beihai Biotech Honored with GHP “Most Innovative Clinical-Stage Biopharmaceutical Company 2023”

2023-08-01
Beihai Biotech Secures “Drug Manufacturing Certificate”

2023-06-15
Landmark Clinical Research Findings of Beihai Biotech's BH009 Unveiled at ASCO 2023

2023-06-12
Beihai Biotech Earns a Spot on the “China Future Healthcare Rankings 2023-Top 100 Biomedicine Companies”

2023-05-08
貝海生物用于治療晚期三陰性乳腺癌的創(chuàng)新藥物BH009獲批開(kāi)展II期臨床試驗(yàn)

2023-04-10
貝海生物BH009新藥項(xiàng)目在晚期頭頸部鱗癌和卵巢癌患者中的I期臨床試驗(yàn)完成首例患者給藥

2023-03-09
貝海生物用于治療非肌層浸潤(rùn)性膀胱癌BH011新藥項(xiàng)目II期臨床研究完成首例患者給藥

2023-03-06
貝海生物榮登“投中2022年度銳公司100榜單”

2023-02-03

Contact Information

Company address：Blg 2, No. 6366, Zhuhai Ave., Jinwan, Zhuhai, 519090, China
Tel：0756-6349669
Human resources contact：hr@bayhibiotech.com
Business cooperation contact：hjiang@bayhibiotech.com

: Wechat Official Account

<menu id="3y9xs"></menu>